Mostra i principali dati dell'item

dc.creatorTheodoridis X., Grammatikopoulou M.G., Stamouli E.-M., Talimtzi P., Pagkalidou E., Zafiriou E., Haidich A.-B., Bogdanos D.P.en
dc.date.accessioned2023-01-31T10:07:53Z
dc.date.available2023-01-31T10:07:53Z
dc.date.issued2021
dc.identifier10.1016/j.nut.2020.111024
dc.identifier.issn08999007
dc.identifier.urihttp://hdl.handle.net/11615/79680
dc.description.abstractObjective: Many treatment modalities have been used to manage psoriasis; however, there is, to our knowledge, no pooled estimate for the effectiveness of oral vitamin D supplements in patients with psoriasis. Hence, the aim of the present study was to systematically review and meta-analyze the efficacy of oral vitamin D supplementation in lessening disease severity of patients with psoriasis. Methods: A systematic literature review was performed on the electronic databases PubMed, Embase, and Cochrane Central and the gray literature for retrieving randomized controlled trials comparing oral vitamin D supplementation with placebo. The primary outcome was the change of Psoriasis Area and Severity Index (PASI) score. We used the random effects model for synthesizing the evidence. Results: Of the total 5018 search results, 4 studies were included in the qualitative and 3 studies in quantitative analysis. Vitamin D supplementation was effective in ameliorating the PASI score after 6 mo of intervention (mean difference [MD] = –0.92, 95% confidence interval [CI] = –1.72 to –0.11). However, after the Hartung-Knapp adjustment, the results became non-significant (MD = –0.92, 95% CI = –2.21 to 0.38). Conclusions: A favorable effect of oral vitamin D supplementation in patients with psoriasis could not be verified. More randomized controlled trials with larger sample sizes are needed to produce robust results. © 2020 Elsevier Inc.en
dc.language.isoenen
dc.sourceNutritionen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85095876282&doi=10.1016%2fj.nut.2020.111024&partnerID=40&md5=228c3b4ab714bd8cd243f19415e2c38d
dc.subjectcolecalciferolen
dc.subjectergocalciferolen
dc.subjectplaceboen
dc.subjectvitamin Den
dc.subjectvitamin Den
dc.subjectdisease severityen
dc.subjectdrug efficacyen
dc.subjecthumanen
dc.subjectmeta analysisen
dc.subjectpatient complianceen
dc.subjectpriority journalen
dc.subjectpsoriasisen
dc.subjectPsoriasis Area and Severity Indexen
dc.subjectrandomized controlled trial (topic)en
dc.subjectReviewen
dc.subjectsystematic reviewen
dc.subjecttreatment outcomeen
dc.subjectunspecified side effecten
dc.subjectvitamin supplementationen
dc.subjectdietary supplementen
dc.subjectseverity of illness indexen
dc.subjectDietary Supplementsen
dc.subjectHumansen
dc.subjectPsoriasisen
dc.subjectRandomized Controlled Trials as Topicen
dc.subjectSeverity of Illness Indexen
dc.subjectVitamin Den
dc.subjectElsevier Inc.en
dc.titleEffectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trialsen
dc.typeotheren


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item